What's Happening?
The 20th Edition Project Portfolio and Resource Management Excellence for Pharma and BioTech conference is set to take place in New Jersey from March 18-19, 2026. Organized by Marcus Evans, the event will focus on strengthening portfolio decision-making frameworks amidst regulatory pressures and investment constraints. Attendees will explore governance discipline, cross-functional alignment, and evidence-based valuation, with sessions on advanced analytics and AI for forecasting and risk assessment. Industry leaders from companies like Daiichi Sankyo, Novartis, Merck, and AstraZeneca will share best practices for sustaining long-term R&D competitiveness.
Why It's Important?
This conference is crucial for the pharma and biotech industries as they navigate complex
challenges such as regulatory changes and market disruptions. By focusing on portfolio management and resource optimization, the event aims to equip industry leaders with strategies to enhance innovation and maintain competitiveness. The integration of advanced analytics and AI in decision-making processes reflects the industry's shift towards data-driven approaches, potentially leading to more efficient and effective R&D outcomes. The conference also provides a platform for collaboration and knowledge exchange, fostering partnerships that can drive future growth.
